The global liquid biopsy market size was valued at USD 4.4 billion in 2021 and is expected to reach a value of USD x million by 2028, growing at a CAGR of 18.2% during the forecast period 2022 to 2028. Liquid biopsy is a non-invasive and straightforward alternative to ‘conventional' or surgical biopsies, and it entails the collection and examination of non-solid biological matter,...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian